These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10858507)

  • 1. Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes.
    Serradeil-Le Gal C; Lafontan M; Raufaste D; Marchand J; Pouzet B; Casellas P; Pascal M; Maffrand JP; Le Fur G
    FEBS Lett; 2000 Jun; 475(2):150-6. PubMed ID: 10858507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
    Nilsson T; Erlinge D; Cantera L; Edvinsson L
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):764-8. PubMed ID: 8961073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
    Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
    J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Br J Pharmacol; 2003 Aug; 139(7):1360-8. PubMed ID: 12890716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.
    Goumain M; Voisin T; Lorinet AM; Ducroc R; Tsocas A; Rozé C; Rouet-Benzineb P; Herzog H; Balasubramaniam A; Laburthe M
    Mol Pharmacol; 2001 Jul; 60(1):124-34. PubMed ID: 11408607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
    Malmström RE; Hökfelt T; Björkman JA; Nihlén C; Byström M; Ekstrand AJ; Lundberg JM
    Regul Pept; 1998 Sep; 75-76():55-70. PubMed ID: 9802394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of cloned chicken neuropeptide Y receptors Y1 and Y5.
    Holmberg SK; Mikko S; Boswell T; Zoorob R; Larhammar D
    J Neurochem; 2002 May; 81(3):462-71. PubMed ID: 12065655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics of NPY Y1 receptor activation.
    Sylte I; Andrianjara CR; Calvet A; Pascal Y; Dahl SG
    Bioorg Med Chem; 1999 Dec; 7(12):2737-48. PubMed ID: 10658578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.
    Robidoux J; Simoneau L; St-Pierre S; Ech-Chadli H; Lafond J
    Am J Physiol; 1998 Mar; 274(3):E502-9. PubMed ID: 9530134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
    Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
    Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
    Gicquiaux H; Tschöpl M; Doods HN; Bucher B
    Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding.
    Shaw JL; Gackenheimer SL; Gehlert DR
    J Chem Neuroanat; 2003 Nov; 26(3):179-93. PubMed ID: 14615027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.
    Castan I; Valet P; Quideau N; Voisin T; Ambid L; Laburthe M; Lafontan M; Carpéné C
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1141-7. PubMed ID: 7910434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
    Körner M; Reubi JC
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of receptor-ligand interactions of the human neuropeptide Y receptor Y1: a site-directed mutagenesis study.
    Sjödin P; Holmberg SK; Akerberg H; Berglund MM; Mohell N; Larhammar D
    Biochem J; 2006 Jan; 393(Pt 1):161-9. PubMed ID: 16097949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.